Driehaus Capital Management LLC Spring Works Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

$9.13 Billion
Q1 2024

A detailed history of Driehaus Capital Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 103,643 shares of SWTX stock, worth $3.95 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

103,643

Previous 136,624 24.14%

Holding current value

$3.95 Million

Previous $4.99 Million 2.31%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.5 - $52.5 $1.2 Million - $1.73 Million	-32,981 Reduced 24.14%	103,643 $5.1 Million
Q4 2023 Feb 14, 2024	SELL	$18.94 - $37.24 $7.53 Million - $14.8 Million	-397,721 Reduced 74.43%	136,624 $4.99 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $20,553 - $27,896	-889 Reduced 0.17%	534,345 $12.4 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $540,205 - $763,287	-23,335 Reduced 4.18%	535,234 $14 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $7.17 Million - $9.77 Million	287,066 Added 105.73%	558,569 $14.4 Million

Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $56,671 - $74,901	-2,608 Reduced 0.95%	271,503 $7.06 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $21.5 Million - $35.4 Million	-891,713 Reduced 76.49%	274,111 $7.82 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $12.4 Million - $40.6 Million	-675,975 Reduced 36.7%	1,165,824 $28.7 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $2.64 Million - $3.53 Million	53,897 Added 3.01%	1,841,799 $104 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $8.14 Million - $11.6 Million	152,755 Added 9.34%	1,787,902 $111 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $16.3 Million - $22.9 Million	259,372 Added 18.85%	1,635,147 $104 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $7.67 Million - $9.74 Million	113,700 Added 9.01%	1,375,775 $113 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $6.95 Million - $9.99 Million	106,766 Added 9.24%	1,262,075 $92.9 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $8.72 Million - $14.1 Million	180,394 Added 18.5%	1,155,309 $83.8 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $1.15 Million - $1.65 Million	-31,687 Reduced 3.15%	974,915 $46.5 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $5.89 Million - $12.4 Million	256,261 Added 34.15%	1,006,602 $42.3 Million
Q1 2020 May 15, 2020	BUY	$20.44 - $41.21 $3.29 Million - $6.63 Million	160,859 Added 27.29%	750,341 $20.3 Million
Q4 2019 Feb 12, 2020	BUY	$17.74 - $39.52 $4.01 Million - $8.94 Million	226,222 Added 62.28%	589,482 $22.7 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $6.83 Million - $10.1 Million	363,260 New	363,260 $7.88 Million

Others Institutions Holding SWTX

# of Institutions

234

Shares Held

67.7M

Call Options Held

546K

Put Options Held

29.4K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.38B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Spring Works Therapeutics, Inc. Transaction History